These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 34135888)

  • 1. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
    Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
    Front Immunol; 2021; 12():642383. PubMed ID: 34135888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern approaches to accelerate discovery of new antischistosomal drugs.
    Neves BJ; Muratov E; Machado RB; Andrade CH; Cravo PV
    Expert Opin Drug Discov; 2016 Jun; 11(6):557-67. PubMed ID: 27073973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.
    Mafud AC; Ferreira LG; Mascarenhas YP; Andricopulo AD; de Moraes J
    Trends Parasitol; 2016 Nov; 32(11):874-886. PubMed ID: 27593339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence-guided approach for efficient virtual screening of hits against
    Moreira-Filho JT; Neves BJ; Cajas RA; Moraes J; Andrade CH
    Future Med Chem; 2023 Nov; 15(22):2033-2050. PubMed ID: 37937522
    [No Abstract]   [Full Text] [Related]  

  • 5. Target-based molecular modeling strategies for schistosomiasis drug discovery.
    Ferreira LG; Oliva G; Andricopulo AD
    Future Med Chem; 2015; 7(6):753-64. PubMed ID: 25996068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
    Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
    ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
    Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
    Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward organometallic antischistosomal drug candidates.
    Hess J; Keiser J; Gasser G
    Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.
    Abdul-Ghani RA; Loutfy N; Hassan A
    Parasitol Res; 2009 Oct; 105(4):899-906. PubMed ID: 19588166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Algorithmic Mapping and Characterization of the Drug-Induced Phenotypic-Response Space of Parasites Causing Schistosomiasis.
    Singh R; Beasley R; Long T; Caffrey CR
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):469-481. PubMed ID: 27071187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current drug strategies for the treatment and control of schistosomiasis.
    Villamizar-Monsalve MA; López-Abán J; Vicente B; Peláez R; Muro A
    Expert Opin Pharmacother; 2024 Mar; 25(4):409-420. PubMed ID: 38511392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products as leads in schistosome drug discovery.
    Neves BJ; Andrade CH; Cravo PV
    Molecules; 2015 Jan; 20(2):1872-903. PubMed ID: 25625682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads.
    Panic G; Keiser J
    Curr Opin Pharmacol; 2018 Oct; 42():27-33. PubMed ID: 30077117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarials in the treatment of schistosomiasis.
    Keiser J; Utzinger J
    Curr Pharm Des; 2012; 18(24):3531-8. PubMed ID: 22607145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.